Omga Liquidating, Inc.
Records under this name other than patents Omga Liquidating, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Omga Liquidating, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,987,791 | Compositions and Methods for Modulating Hepatocyte Nuclear Factor 4-Alpha (HNF4alpha) Gene Expression now held by Sepia Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| 17/701,325 | Compositions and Methods for Modulating Apolipoprotein B (APOB) Gene Expression now held by Sepia Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 17/929,828 | Compositions and Methods for Modulating Forkhead Box P3 (FOXP3) Gene Expression now held by Sepia Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/405,286 | Compositions and Methods for Modulating Secreted Frizzled Receptor Protein 1 (SFRP1) Gene Expression now held by Sepia Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/637,630 | Compositions and Methods for Modulating Hepatocyte Nuclear Factor 4-Alpha (HNF4alpha) Gene Expression now held by Sepia Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |